PepRank

Glatiramer acetate

37%positive24 reports

Also: Copaxone · Glatopa (generic) · copolymer 1 / Cop-1 · GA

ExcludedImmuneInjection

Approved MS drug made of random myelin-mimicking peptide chains; modest relapse cut, injection burden.

#60 of 61 research peptides · updated
Onset
Relapse reduction builds over months; the trials measured it at one to two years. Nothing is felt from a dose except site reactions.
Lasts
Continuous treatment; the effect lasts only while it is taken.
Access
Approved drug
Cost / month
Usually covered by insurance or national health systems; a specialty-drug price in the US (thousands of dollars a month at list), far less in Europe and as generics.
24 user reports
Glowing 2Positive 6Mixed 4Nothing 2Negative 4Bad reaction 6

  • r/MultipleSclerosis· · 3 upvotesOriginal ↗

    My Neurologist says this DMT is the reason I can still walk unaided.

    GlowingImmune · 20 mg daily · Injection · since 1996 (~10,000 injections)

    relapsing MS

  • r/MultipleSclerosis· · 3 upvotesOriginal ↗

    12 years on Copaxone and no relapses. All MRIs showing no new issues as well.

    GlowingImmune · Injection · 12 years

    relapsing MS

  • r/MultipleSclerosis· · 6 upvotesOriginal ↗

    I had the bad reaction about 6 months into starting it. It's what I imagine death feels like.

    Bad reactionImmune · Injection · ~1 year

    relapsing MS

Strict case
Prescription immunomodulator for relapsing MS with an FDA boxed warning for anaphylaxis (82 cases, 6 deaths reported to 2024, some years into treatment), plus label warnings for liver injury and skin necrosis. Worth it for MS under a neurologist; not a self-directed peptide.
Users report
Split. Long-term users (10-29 years) credit it with stable MRIs and staying mobile, and value its lack of immunosuppression, which also makes it the usual choice around pregnancy and breastfeeding. Against that: near-universal injection-site pain, welts and lumps, permanent fat loss (lipoatrophy) and in some cases skin necrosis; frightening immediate post-injection reactions (chest tightness, flushing, palpitations, 'what I imagine death feels like'), sometimes first appearing after years; and several first-hand anaphylaxis reports needing the ER and epinephrine. Reaction threads were searched on purpose, so bad reactions are over-represented in these 24 reports. Current community and specialist consensus favours starting on higher-efficacy drugs (anti-CD20s) instead. Felt nothing: Two of 24 reports describe new lesions or relapses with no benefit; r/MultipleSclerosis regulars widely call it the least effective DMT..
Best effects
Fewer relapses (about 30% fewer than placebo in trials) · fewer new MRI lesions · not broadly immunosuppressive · usable in pregnancy and breastfeeding
Downsides
Injection-site pain, welts, lumps and bruising · permanent lipoatrophy (dents) at injection sites · immediate post-injection reaction (flushing, chest pain, palpitations, breathlessness; about 16% on the daily dose) · transient chest pain unrelated to injections · daily or three-times-weekly self-injection
Watch
Anaphylaxis, including fatal, at any point in treatment (FDA boxed warning, January 2025: 82 worldwide cases, 6 deaths) · Hepatic injury including liver failure and hepatitis with jaundice, days to years after starting (label warning) · Injection-site skin necrosis (postmarketing) · Immune modulation; antibodies to the drug form in most patients (label precaution)
Evidence
Approved drug — FDA-approved for relapsing MS since 1996, EU and worldwide; several placebo-controlled RCTs (n up to 1,404). No benefit on progression in primary progressive MS (PROMiSe, n=943). Remyelination evidence is animal only.
Caveat
Among MS drugs it is one of the lowest-efficacy options, and specialists now often start with high-efficacy drugs; its place today is mainly where its safety profile matters (pregnancy, breastfeeding, people who want to avoid immunosuppression). Remyelination or 'repair' is shown only in mice. Generic and brand versions are interchangeable in the US; some users report more reactions after switching, which has not been shown.
Typical use
20 mg subq daily, or 40 mg subq three times a week at least 48 hours apart (the doses are not interchangeable).
Getting it
Prescription only, from a neurologist, via specialty pharmacy (Copaxone, the generic Glatopa and other generics). Not sold by research-peptide vendors.
Stacked with
Vitamin D: Commonly taken alongside by MS patients on any disease-modifying drug. · Benadryl and Tylenol before injecting: Some users pre-medicate to blunt post-injection reactions; this does not prevent anaphylaxis.

User reports 24

  • r/MultipleSclerosis· · 3 upvotesOriginal ↗

    My Neurologist says this DMT is the reason I can still walk unaided.

    GlowingImmune · 20 mg daily · Injection · since 1996 (~10,000 injections)

    relapsing MS

  • r/MultipleSclerosis· · 3 upvotesOriginal ↗

    12 years on Copaxone and no relapses. All MRIs showing no new issues as well.

    GlowingImmune · Injection · 12 years

    relapsing MS

  • r/MultipleSclerosis· · 120 upvotesOriginal ↗

    I have now given myself shots for 5 years 3 times a week and haven't had any new lesions!

    PositiveImmune · 40 mg 3x/week · Injection · 5 years

    relapsing MS

  • r/MultipleSclerosis· · 4 upvotesOriginal ↗

    Been on copaxone for nearly 11 years,got my yearly MRI results afew months ago and there has been zero change so copaxone seems to be working well for me

    PositiveImmune · Injection · ~11 years

    relapsing MS

  • r/MultipleSclerosis· · 4 upvotesOriginal ↗

    I'd describe it as suddenly feeling like I had flu, felt cold all over and shaky, I went back to bed shivering and fell asleep then woke up 20-30 mins later and it had gone.

    PositiveImmune · Injection · ~7 years

    relapsing MS

  • r/MultipleSclerosis· · 4 upvotesOriginal ↗

    Was on it for a decade, no prob save for subcutaneous fat destruction around the injection sites

    PositiveImmune · Injection · ~10 years

    relapsing MS

  • r/MultipleSclerosis· · 2 upvotesOriginal ↗

    However it seemed to have helped my fatigue and brain fog vastly.

    PositiveImmune · Injection · 7-8 years

    relapsing MS

  • r/MultipleSclerosis· · 1 upvotesOriginal ↗

    I had zero progression and it worked like a dream. Sadly being on it for so long my body started to necrosis at some injection sites

    PositiveImmune · Injection · 12+ years

    brain-only lesions

  • r/MultipleSclerosis· · 5 upvotesOriginal ↗

    it seems like 95% of my injections burn, welt, bleed, etc.

    MixedImmune · Injection · ~2 years

    relapsing MS

  • r/MultipleSclerosis· · 3 upvotesOriginal ↗

    Over the few years I probably had bad reactions a half a dozen times.

    MixedImmune · Injection · ~2 years

    primary progressive MS (off-label)

  • r/MultipleSclerosis· · 2 upvotesOriginal ↗

    I was on glatiramer for over a decade and then one night I injected and nearly immediately had some of the worst chills of my life for about 45 minutes. I never took it again.

    MixedImmune · Injection · 10+ years

    relapsing MS

  • r/MultipleSclerosis· · 2 upvotesOriginal ↗

    Maybe once every other month or so I would get this weird reaction right after injection, like a fluttering in my chest?

    MixedImmune · Injection · ~10 years

    relapsing MS, sensitive skin

  • r/MultipleSclerosis· · 1 upvotesOriginal ↗

    I was on it for 14 months and had five new lesions.

    NothingImmune · Injection · 14 months

    relapsing MS

  • r/MultipleSclerosis· · 1 upvotesOriginal ↗

    I was on it for a year and had 2 relapses and multiple new lesions on MRI.

    NothingImmune · Injection · 1 year

    aggressive relapsing MS

  • r/MultipleSclerosis· · 5 upvotesOriginal ↗

    FWIW, Copaxone worsened my MS after just 10 days (in 2009 it was a daily injection), and I ended up hospitalized in a full-blown relapse.

    NegativeImmune · 20 mg daily · Injection · 10 days

    relapsing MS; a relapse this early may be coincidence

  • r/MultipleSclerosis· · 3 upvotesOriginal ↗

    Well it hadn't gone away after 9 months plus now it was causing severe depression and I just couldn't take it anymore.

    NegativeImmune · Injection · ~9 months

    relapsing MS

  • r/MultipleSclerosis· · 2 upvotesOriginal ↗

    Yes and I also developed 3-4 inch hives all over my body.

    NegativeImmune · Injection

    relapsing MS

  • r/MultipleSclerosis· · 1 upvotesOriginal ↗

    I was on GA for about 4 months before i had to stop because my welts just stopped going away and were always there.

    NegativeImmune · Injection · ~4 months

    relapsing MS

  • r/MultipleSclerosis· · 6 upvotesOriginal ↗

    I had the bad reaction about 6 months into starting it. It's what I imagine death feels like.

    Bad reactionImmune · Injection · ~1 year

    relapsing MS

  • r/MultipleSclerosis· · 3 upvotesOriginal ↗

    The ER doctor told me I was in anaphylaxis and the epi pen and Benadryl worked.

    Bad reactionImmune · Injection

    relapsing MS, on it for some time

  • r/MultipleSclerosis· · 2 upvotesOriginal ↗

    I experienced the same pretty much exactly a year ago after seven years on glatiramer. Tight chest, struggling to breathe, head seems to explode.

    Bad reactionImmune · Injection · 7 years

    relapsing MS

  • r/MultipleSclerosis· · 2 upvotesOriginal ↗

    Unfortunately, I had an allergic reaction to it, so I got chills and shortness of breath.

    Bad reactionImmune · Injection

    relapsing MS (Germany)

  • r/MultipleSclerosis· · 1 upvotesOriginal ↗

    My second injection (on my birthday) I went into anaphylactic shock…. Rushed to the ER… hives the whole “I think I may die” hard to breathe thing.

    Bad reactionImmune · Injection

    restarted on the three-times-weekly form years after the daily one

  • r/MultipleSclerosis· · 1 upvotesOriginal ↗

    Copaxone caused my skin to blister anywhere it touched me, and all my sites began to turn black and necrotize.

    Bad reactionImmune · Injection

    relapsing MS, antibodies to the interferons

Safety

Tier by safety barStrict ExcludedBalanced ExcludedEvidence only Excluded

Seen harmMechanismData gapSilent harmProduct

Seen harm 3/3
The FDA attributes 82 worldwide anaphylaxis cases (1996 to May 2024) to glatiramer acetate, all needing emergency care or hospitalisation and six fatal, and added a boxed warning in January 2025; the label also warns of hepatic injury including liver failure and of injection-site skin necrosis. First-hand Reddit reports of ER-treated anaphylaxis match. FDA Drug Safety Communication: boxed warning for anaphylaxis (Jan 2025) ↗Copaxone prescribing information (FDA, revised 1/2025) ↗
Mechanism 2/3
An antigenic random polymer that deliberately modulates the immune response: drug-reactive IgG antibodies form in most patients, IgG rose to 3x baseline in 80% within 3 months, immune-complex deposition in kidneys was seen in rats and monkeys, and the label flags possible effects on tumour surveillance and infection defences without evidence of either. That is the immune-activation category, not a demonstrated in-vivo oncogenic or organ-damage pathway. Copaxone prescribing information, 5.5 Potential Effects on Immune Response ↗
Data gap 0/3
FDA-approved since 1996 with placebo-controlled RCTs including 251, 943 and 1,404 patients, a Cochrane review, a pregnancy database and nearly 30 years of post-marketing use (about 240,000 US prescriptions in 2023). Khan et al. 2013 (GALA), n=1,404 ↗Johnson et al. 1995, n=251 ↗Cochrane 2010: glatiramer acetate for multiple sclerosis ↗
Silent harm 2/3
Anaphylaxis itself is immediate and obvious (alone it would be a 1, since it can first appear years into treatment), but the label's hepatic injury can develop days to years after starting and shows on liver tests before it is felt, and lipoatrophy builds slowly and is permanent. Copaxone prescribing information, 5.4 Lipoatrophy and 5.6 Hepatic Injury ↗
Product 0/3
Bought only as a manufactured, regulated prescription product (Copaxone, Glatopa or other generics) from specialty pharmacies, self-injected subq from prefilled syringes; no grey-market or compounded supply. Product risk is technique (hitting a vessel, poor site rotation), not purity or sterility. Copaxone prescribing information, 2 Dosage and Administration ↗
Never if
Known hypersensitivity to glatiramer acetate or mannitol (label) · Any previous anaphylaxis on glatiramer acetate, unless another clear cause is identified (boxed warning) · Primary progressive MS as the reason for use (no benefit in the PROMiSe trial)

Studies 6

Sources 4

More in Neuroprotection & repair all 10 →

  1. 1ARA-290 QEQLERALNSS (11 residues) Caution Injection≈ €180–630 / month56%positive40 reportsNon-erythropoietic EPO-derived peptide for small-fibre neuropathy pain.
  2. 2Cortexin Caution Injection≈ €36–90 / month50%positive20 reportsRussian brain-cortex extract, Cerebrolysin cousin; 10-day IM courses.Animal-brain extract given by injection: immune/allergic and theoretical prion risk, and it shares Cerebrolysin's SAE signal.
  3. 3P21 (P021) DGGL (4 residues) Caution Nasal / Oral / Injection≈ €45–180 / month43%positive15 reportsCNTF-derived neurogenic peptide from Alzheimer's mouse work; grey market only.No human safety data; deliberately drives neurogenesis via a growth-factor pathway, and products are of uncertain identity.
  4. 4NAP / Davunetide NAPVSIPQ (8 residues) Clean Nasal2/10estimateADNP-derived microtubule-stabilising peptide; safe in a large trial but ineffective.
  5. 5Dihexa YI (2 residues) Excluded Oral / Topical / Injection≈ €13–53 / month50%positive30 reportsAngiotensin-IV analogue claimed as potent synaptogenic; hyped, not evidenced in humans.Activates the oncogenic HGF/c-Met pathway, has no human safety data, and its foundational studies are under expressions of concern.
  6. 6Humanin MAPRGFSCLLLLTSEIDLPVKRRA (24 residues) Excluded Injection43%positive1 reportsMitochondrial-derived cytoprotective peptide; anti-Alzheimer's in animals only.Its anti-apoptotic action helps glioma cells survive chemotherapy in animal studies, and there is no human data.
  7. 7FGL EVYVVAENQQGKSKA (15 residues) Excluded Nasal / Injection43%positive1 reportsNCAM mimetic that activates FGF receptors; rodent memory data only.Agonist of the mitogenic FGF receptor, with only phase-1 data and no users to learn from.
  8. 8Cerebrolysin Excluded Nasal / Injection / IV≈ €140–540 / month40%positive29 reportsPig-brain peptide mix for stroke/TBI; strong anecdotes, real safety questions.Cochrane found more non-fatal serious adverse events than placebo; animal-derived injectable with allergy/immune reaction risk.
  9. 9Corticotropin (repository ACTH gel) Excluded Injection43%positive15 reportsPituitary hormone gel approved for MS relapses; works like steroids, costs like a luxury car.Drives the adrenals to flood the body with cortisol, so it carries the corticosteroid label warnings (infection, Cushing's syndrome, adrenal insufficiency on withdrawal, GI perforation, psychosis, high blood pressure and glucose, bone loss) plus anaphylaxis. A prescription relapse treatment under a neurologist, not something to take outside one.

Sequence beads

Each bead is one amino acid in the peptide's chain, coloured by its side chain: grey for non-polar, cyan for polar, blue for positively charged and fuchsia for negatively charged. Length and mix tell related peptides apart at a glance, from a two-residue dipeptide like carnosine to a 43-residue protein like thymosin beta-4. The colours describe chemistry only and predict neither effect nor safety.

non-polarpolarpositivenegative

Report grades

Every first-hand Reddit or X report is graded on its own, from glowing through positive, mixed, nothing and negative to bad reaction, and the bar shows how those grades split. Posts that look vendor-adjacent stay on the peptide's page but are left out of the counts.

GlowingPositiveMixedNothingNegativeBad reaction

% positive

The share of a peptide's graded Reddit and X reports that are glowing or positive, vendor-adjacent posts left out. A peptide with few reports is pulled toward the average of all reports, as if it had eight average ones besides its own, so two glowing posts cannot top the list. Kept peptides rank by the same reports' mean grade, shrunk the same way, and excluded ones follow in that order.

Researcher estimate

No first-hand report of this peptide has been graded yet, so the figure is the researchers' own rating out of 10 from what they read about it. It ranks alongside the computed scores until reports arrive.

Safety tier

Each peptide is tiered clean, caution or excluded from its five risk axes under the chosen safety bar. An excluded peptide has a plausible route to serious harm, so it stays listed with the reason but ranks behind every other entry, however good its reviews.

Safety bar

The safety bar sets how much risk it takes to exclude a peptide. Strict: out on any serious mechanism with little human data, or any documented serious harm. Balanced: out on documented serious harm (unless it is obvious, reversible and from a regulated product), or a serious mechanism whose harm would be silent with no human data at all. Evidence only: out only on documented serious harm in humans that is lasting, delayed or from grey-market product.

Seen harm

Documented serious adverse events in humans, from 0 for none despite real exposure to 3 for deaths or several well-documented serious harms. Serious means a hospital or emergency visit or harm lasting weeks, so a headache or a bad night does not count.

Mechanism

A plausible biological route to serious harm at the doses people use, such as growth-factor signalling, hormone-axis suppression, heart or blood-pressure effects or immune activation. It runs from 0 when none is known to 3 when a dangerous pathway has been shown in living animals.

Data gap

How little human safety data exists for the molecule actually sold, from 0 for an approved drug with large trials and years of use to 3 for no human safety data at all. A modified analogue does not inherit its parent's trials.

Silent harm

Whether the feared harm would show quickly or stay hidden, from 0 when it is obvious and goes on stopping to 3 when it is silent and delayed, like tumour promotion or slow organ damage. User reports cannot reveal a harm that takes years to appear, so a high score here limits what good reviews can tell you.

Product

The risk of what people actually buy, from 0 for a regulated pharmacy or supplement product taken by mouth or on the skin to 3 for a grey-market injectable. In one dataset of 6,441 grey-market samples, 42–71% failed basic quality criteria and 15% carried endotoxin.

Evidence

The strongest kind of study behind the peptide's effects, from an approved drug through human controlled trials and small human studies to animal work or nothing of its own. Animal results often fail to carry over to people.

Access

How people get it: as an approved drug, a compounded prescription, an over-the-counter supplement or from the grey market, where nobody checks the vial. The channel decides both the legal position and the risk of a bad batch.

Price per month

Thirty days of the typical dose, from its low end to its high end, priced at the listing a careful buyer would choose: in stock, from a shop scoring 4 of 5 on trust (third-party tested where no score is set), failing that 3, a pure pack before a blend, a European shop first, then the cheapest per mg. The range is the dose's, not the shops'. A per-dose amount counts once a day unless the dose says otherwise. Prices are in euros at ECB rates of 2026-10-29, before shipping; the shop table keeps each listing's price per mg, per gram for bulk supplements. Where no listing can be priced the researchers' own estimate stands in, and says so.

Dose users report

The middle half of the daily doses stated in at least five first-hand reports, vendor posts left out. Where its middle sits more than twice above or below the declared dose, the month is priced at it as well, since what people take is what they pay for.

Testing

Whether the shop publishes lab results: third-party tested means an independent lab checks each batch, own COA means the shop's own certificate of analysis, and no public tests means neither. A certificate shows purity, not safety.

Added peptide

Some packs sold under one peptide's name hold a second one, such as 5 mg GHK-Cu in a nasal kit, stated only in the description. Sprayed in the nose or injected it reaches the blood like an injection, so it carries the risk of that route and is tiered as the injectable form, whatever its tier on the skin. A pack whose page gives no contents list may hold more than its name.